|
Ongoing Projects |
|
|
2023-2028 |
Team member, TA ČR (TN02000122) |
|
Recombinant Technologies for Medicine (RETEMED) |
|
|
2023-2025 |
Co-investigator, GAČR 23-05805S |
|
Ligands for the Mannose-6-Phosphate/Insulin-Like Growth Factor 2 Receptor and Their In Vitro Effects in Pathological and Nervous Processes |
|
|
2023-2026 |
TA ČR National Centres of Competence; TN02000122/001N |
|
Therapeutics of Recombinant and Natural Origin (TEREP) |
|
|
Completed Projects |
|
|
2021-2025 |
Co-investigator, Gilead Sciences Research Center IV |
|
Inhibitors of Therapeutically Relevant Galectins |
|
|
2018-2022 |
Team member, MEYS, OP EU, project No. 16_025/0007397_01 |
|
Centre for Recombinant Biotechnology and Immunotherapeutics (CEREBIT) |
|
|
2022-2024 |
Team member, GAČR, No. 22-17586S |
|
15N Isotopic Labelling in NMR Structural Analysis of N-Disaccharides |
|
|
2017-2021 |
Co-investigator, Gilead Sciences Research Center III |
|
Enzymatically Stable Galectin Inhibitors |
|
|
2017-2021 |
Team member, GAČR, No. 15-17572S |
|
Calix[4]arene/C-Oligosaccharide Glycocluster Design for Improved Selectivity of Lectin Interactions |
|
|
2016-2020 |
Team member, TA ČR, TH02030874 |
|
Novel Impedimetric Biosensors for Real-Time Monitoring of Trace Xenobiotic Contamination of Groundwater |
|
|
2016-2019 |
Team member, MPO 2016FV10312 |
|
Biosensors for the Detection of Bacterial Contamination of Drinking Water |
|
|
2016-2019 |
Team member, MPO 2016FV10810 |
|
Development of a Manufacturing Technology for the Peptide Substance [D-Phe6]-Gonadorelin for Pharmaceutical Production |
|
|
2012-2014 |
Principal investigator, GAČR, No. P207/12/P713 |
|
A New Pd-Catalysed Modular Approach to Non-Hydrolysable Vectors for Transfection Systems |
|
|
2010-2011 |
Team member, FP7-HEALTH, project ref. 201095 |
|
HIV ACE (Targeting the Assembly of Infectious HIV Particles) |
|
|
2008-2010 |
Team member, GAČR, No. 203/08/1124 |
|
Stereoselective Synthesis of Disaccharide Analogues |
|